CSIMarket


Nurix Therapeutics Inc   (NRIX)
Other Ticker:  
 

Nurix Therapeutics Inc

NRIX's Fundamental analysis








Looking into Nurix Therapeutics Inc growth rates, revenue grew by 123.49 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 532

Major Pharmaceutical Preparations industry recorded deterioration of revenues by

Nurix Therapeutics Inc net loss deacreased by in IV. Quarter 2023 year on year, Nurix Therapeutics Inc net loss increased by -10.19 % in IV. Quarter 2023 year on year,

More on NRIX's Growth


Nurix Therapeutics Inc
realized net loss in trailing twelve months.

Nurix Therapeutics Inc realized cash outflow of $ -0.18per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
288.46
PE TTM    
Company's Price to Sales ratio is at 8.38.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.83.


More on NRIX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 769,870
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 3.69

Nurix Therapeutics Inc
realized net loss in trailing twelve months.

Nurix Therapeutics Inc realized cash outflow of $ -0.18per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
288.46
PE TTM    
Company's Price to Sales ratio is at 8.38.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.83.

Nurix Therapeutics Inc Price to Book Ratio is at 3.22 lower than Indusry Avg. of 1317.65. and higher than S&P 500 Avg. of -2060.44

More on NRIX's Valuation

  Market Capitalization (Millions $) 645
  Shares Outstanding (Millions) 54
  Employees 100
  Revenues (TTM) (Millions $) 77
  Net Income (TTM) (Millions $) -144
  Cash Flow (TTM) (Millions $) -10
  Capital Exp. (TTM) (Millions $) -8
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 769,870
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 3.69

  Market Capitalization (Millions $) 645
  Shares Outstanding (Millions) 54
  Employees 100
  Revenues (TTM) (Millions $) 77
  Net Income (TTM) (Millions $) -144
  Cash Flow (TTM) (Millions $) -10
  Capital Exp. (TTM) (Millions $) -8





  Ratio
   Capital Ratio (MRQ) 3.4
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.77
  Asset Turnover Ratio (TTM) 0.22
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com